Eric Brunk
Aerospace Medicine Nellis Afb, NV Doctor of Osteopathy
NPI 1972958700 CMS profile 5692220
4700 Las Vegas Blvd N, Nellis Afb, NV 89191
General payments
$1,105
Research payments
$0
Ownership & investment interest
$0
Through program year 2025, Eric Brunk of Nellis Afb, NV is reported in the CMS Open Payments database as having received $1,105 across 12 general payments and $0 in research payments paid to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
General payments for this record sit in the 90th percentile of Aerospace Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
2 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2025 | General | $1,077 | 11 | |
| 2023 | General | $28 | 1 |
Beside peers
- Eric Brunk
- Aerospace Medicine median
- Middle half of Aerospace Medicine
- National median
In program year 2025, general payments to Eric Brunk were reported at $1,077. Among 42 Aerospace Medicine profiles paid that year, the median was $90 and the middle half received between $33 and $238.
Show as a table
| Year | Eric Brunk | Aerospace Medicine median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $0 | $54 | $26–$230 | $163 |
| 2020 | $0 | $62 | $20–$173 | $114 |
| 2021 | $0 | $118 | $44–$253 | $132 |
| 2022 | $0 | $50 | $16–$110 | $149 |
| 2023 | $28 | $108 | $25–$207 | $160 |
| 2024 | $0 | $52 | $27–$373 | $164 |
| 2025 | $1,077 | $90 | $33–$238 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Prescribing to Medicare patients
Part D · data year 2024 · 1 drugPart D claims
13
Drug cost
$235
Branded share of claims
0%
| Drug | Type | Relative to their largest | Claims | Drug cost |
|---|---|---|---|---|
| Gabapentin | Generic | 13 | $235 |
Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 584 Part D prescribers listed as Preventive Medicine; they describe a distribution and say nothing about conduct.
Records
12 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Aerospace Medicine in Nevada
Jacob Hall
Aerospace Medicine · Nellis Afb, NV
Travis Grindstaff
Aerospace Medicine · Nellis Afb, NV
Randy Butler
Aerospace Medicine · Las Vegas, NV
Jean-Gabriel Coignet
Aerospace Medicine · Nellis Afb, NV
Joseph Hudson
Aerospace Medicine · Nellis Afb, NV
Eric Hanson
Aerospace Medicine · Las Vegas, NV
Related records
Aerospace Medicine in Nevada
Practitioners in the same specialty and state, ranked by reported value.
All Aerospace Medicine
Everyone recorded under this specialty, nationwide.
Doctors in Nevada
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.